Home » Topics » Conferences

Conferences
RSS

Melatonin for treatment of fibromyalgia syndrome

Sep. 26, 1997

R-PIA active in rodent model of neuropathic central pain

Sep. 26, 1997

L-Arginine for liver ischemia/reperfusion injury and transplantation

Sep. 25, 1997

FTY-720: novel immunosuppressant for combination therapy

Sep. 25, 1997

Colonic prokinetic agent discovered by Janssen

Sep. 25, 1997

Yamanouchi develops potent and selective PDE IV inhibitors

Sep. 25, 1997

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

Nonsteroidal inhibitors of steroid C17,20-lyase developed at Yamanouchi

Sep. 25, 1997

Spotlight on bisphosphonates in osteoporosis

Sep. 25, 1997

LY-303366: efficacy in rabbits with invasive pulmonary aspergillosis

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...